Skip To The Main Content
PDA Comments: PDA Input on USP 2020-2025 Revision Cycle
Nov 4, 2019
PDA Comments: PDA Responds to EMA Combo Product Reg
Nov 4, 2019
PDA Comments: Suggestions for FDA Voluntary Recalls Doc
Sep 30, 2019
PDA Comments: Concerns About USP <1235> Revision
Aug 26, 2019
PDA Comments: Full Support for WHO WFI Guidance
Jul 8, 2019
PDA Comments: Ph. Eur. Tackles Endotoxin Alternative rFC
May 28, 2019
PDA Comments: Drug Storage Regulations in Plain Language
Apr 29, 2019
Risk-Benefit Analysis More of NCA Scope
Oct 1, 2018
PDA Responds to Annex 1 Revision
Apr 30, 2018
Changes to USP Council of Experts
Feb 26, 2018
Flexibility Needed for PAC
Jan 2, 2018
CFDA Encouraged to Review PDA Docs
Nov 6, 2017
WHO Should Align with ICH on PACs
Apr 4, 2017